Senior insider sale
President at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$111.9K
24.58K shares
What this filing means
VOLPONE JOHN plans to sell 24.58K shares of X4 PHARMACEUTICALS, INC valued at approximately $111.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0002081729-26-000004
Officer· President
Since Aug 2025
24.58K
Shares to sell
$111.9K
Approx. market value
96.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
8/12/2026
96.63KTotal acquired96.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2026 | Restricted Stock Unit Vesting Compensation | 96.63K | — |
| Total | 96.63K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
24.58K
Market value
$111.9K
8/12/2026
Total
Units
24.58K
Value
$111.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2026 | 24.58K | $111.9K | NASDAQ | Planned |
| Total | 24.58K | $111.9K | ||